MedKoo Cat#: 534604 | Name: Halicin
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Halicin ia s novel inhibitor of the c-Jun N-Terminal kinase.

Chemical Structure

Halicin
Halicin
CAS#40045-50-9

Theoretical Analysis

MedKoo Cat#: 534604

Name: Halicin

CAS#: 40045-50-9

Chemical Formula: C5H3N5O2S3

Exact Mass: 260.9449

Molecular Weight: 261.29

Elemental Analysis: C, 22.98; H, 1.16; N, 26.80; O, 12.25; S, 36.81

Price and Availability

Size Price Availability Quantity
50mg USD 450.00 2 Weeks
100mg USD 750.00 2 Weeks
250mg USD 1,450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Halicin; SU-3327; SU 3327; SU3327
IUPAC/Chemical Name
5-[(5-Ntro-1,3-thiazol-2-yl)sulfanyl]-1,3,4-thiadiazol-2-amine
InChi Key
NQQBNZBOOHHVQP-UHFFFAOYSA-N
InChi Code
InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8)
SMILES Code
NC1=NN=C(SC2=NC=C([N+]([O-])=O)S2)S1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 261.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kutlu Z, Celik M, Bilen A, Halıcı Z, Yıldırım S, Karabulut S, Karakaya S, Bostanlık DF, Aydın P. Effects of umbelliferone isolated from the Ferulago pauciradiata Boiss. & Heldr. Plant on cecal ligation and puncture-induced sepsis model in rats. Biomed Pharmacother. 2020 May 4;127:110206. doi: 10.1016/j.biopha.2020.110206. Epub ahead of print. PMID: 32407990. 2: Polat G, Ugan RA, Cadirci E, Halici Z. Sepsis and Septic Shock: Current Treatment Strategies and New Approaches. Eurasian J Med. 2017 Feb;49(1):53-58. doi: 10.5152/eurasianjmed.2017.17062. PMID: 28416934; PMCID: PMC5389495. 3: Emet M, Ozcan H, Ozel L, Yayla M, Halici Z, Hacimuftuoglu A. A Review of Melatonin, Its Receptors and Drugs. Eurasian J Med. 2016 Jun;48(2):135-41. doi: 10.5152/eurasianjmed.2015.0267. PMID: 27551178; PMCID: PMC4970552. 4: Seyrek M, Halici Z, Yildiz O, Ulusoy HB. Interaction between dexmedetomidine and α-adrenergic receptors: emphasis on vascular actions. J Cardiothorac Vasc Anesth. 2011 Oct;25(5):856-62. doi: 10.1053/j.jvca.2011.06.006. Epub 2011 Sep 8. PMID: 21862350. 5: Suleyman H, Albayrak A, Bilici M, Cadirci E, Halici Z. Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers. Inflammation. 2010 Aug;33(4):224-34. doi: 10.1007/s10753-009-9176-5. PMID: 20084447. 6: Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem. 2008;15(3):278-83. doi: 10.2174/092986708783497247. PMID: 18333314.